Skip to main page content
Home
Current Issue
Archive
Contact
Subscribe
Alerts
Help
Search
GO
Advanced Search »
User Name
Password
Sign In
Effects of the Dipeptidyl Peptidase-IV Inhibitor Vildagliptin on Incretin Hormones, Islet Function, and Postprandial Glycemia in Subjects With Impaired Glucose Tolerance
Online-Only Appendix
Files in this Data Supplement:
Figure A1: Disposition of Subjects
Figure A2: Plasma levels of active GIP at study endpoint during standard meal tests performed in subjects with IGT receiving vildagliptin or placebo.
Supplemental Figure Legends
This Article
Published online before print
October 18, 2007
, doi:
10.2337/dc07-1616
Diabetes Care
January 2008
vol. 31
no. 1
30-35
Abstract
Free
Full Text
Full Text (PDF)
»
Online-Only Appendix
Current Issue
December 2009, 32 (12)
From the Cover
Driving mishaps among individuals with type 1 diabetes: a prospective study
Projecting the future diabetes population size and related costs for the U.S.
Prospective study of pre-gravid sugar-sweetened beverage consumption and the risk of gestational diabetes mellitus
Are metabolically normal but obese individuals at lower risk for all-cause mortality?
Alert me to new issues of Diabetes Care
Instructions for Authors
Manuscript Submissions
About the Journal
Editorial Board
Subscriptions
PDA Services
Advertising & Reprints
ADA's DiabetesPro
ADA Member Directory
RSS Feeds
E-mail Alerts
Diabetes
Clinical Diabetes
Diabetes Spectrum